FGEN

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

FibroGen Inc

NASDAQ | FGEN

10.71

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$45.21M

Market Cap

-

P/E Ratio

-21.61

EPS

$21.94

52 Week High

$4.50

52 Week Low

HEALTHCARE

Sector

FGEN Chart

Recent Chart
Price Action

FGEN Technicals

Tags:

FGEN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $14M
Total Revenue $30M
Cost Of Revenue $16M
Costof Goods And Services Sold $16M
Operating Income -$150M
Selling General And Administrative $49M
Research And Development $96M
Operating Expenses $164M
Investment Income Net -
Net Interest Income -$3M
Interest Income $5.3M
Interest Expense $8.2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.7M
Income Before Tax -$153M
Income Tax Expense -$269K
Interest And Debt Expense -
Net Income From Continuing Operations -$153M
Comprehensive Income Net Of Tax -
Ebit -$145M
Ebitda -$142M
Net Income -$48M

Revenue & Profitability

Earnings Performance

FGEN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $215M
Total Current Assets $197M
Cash And Cash Equivalents At Carrying Value $50M
Cash And Short Term Investments $50M
Inventory $3.2M
Current Net Receivables $29M
Total Non Current Assets $18M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $114M
Other Non Current Assets -
Total Liabilities $398M
Total Current Liabilities $133M
Current Accounts Payable $5.1M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $265M
Capital Lease Obligations $0
Long Term Debt $73M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $73M
Other Current Liabilities $101M
Other Non Current Liabilities $77M
Total Shareholder Equity -$226M
Treasury Stock -
Retained Earnings -$1.9B
Common Stock $1M
Common Stock Shares Outstanding $100M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$138M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.7M
Capital Expenditures $266K
Change In Receivables -
Change In Inventory $22M
Profit Loss -
Cashflow From Investment $126M
Cashflow From Financing -$255K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $2.2M
Dividend Payout Common Stock $2.2M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$48M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $14M
Total Revenue $30M
Cost Of Revenue $16M
Costof Goods And Services Sold $16M
Operating Income -$150M
Selling General And Administrative $49M
Research And Development $96M
Operating Expenses $164M
Investment Income Net -
Net Interest Income -$3M
Interest Income $5.3M
Interest Expense $8.2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.7M
Income Before Tax -$153M
Income Tax Expense -$269K
Interest And Debt Expense -
Net Income From Continuing Operations -$153M
Comprehensive Income Net Of Tax -
Ebit -$145M
Ebitda -$142M
Net Income -$48M

FGEN News

FGEN Profile

FibroGen Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

FibroGen, Inc. is a biopharmaceutical company based in San Francisco, California, dedicated to developing and commercializing innovative therapies aimed at addressing significant unmet medical needs. Specializing in treatments for anemia associated with chronic kidney disease and fibrotic diseases, FibroGen utilizes its proprietary technology platforms to pioneer novel therapeutics that enhance patient outcomes. The company strategically positions itself within the biopharmaceutical landscape through robust research initiatives and partnerships, thereby expanding its portfolio and reinforcing its commitment to delivering impactful healthcare solutions.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
IONQ
+7.06%
$59.37
DNN
+0.18%
$2.72
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RGTZ
-20.27%
$14.90
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
AMC
-0.72%
$2.73
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
MARA
+0.36%
$19.22
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
DVLT
+5.14%
$2.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
IONQ
+7.06%
$59.37
DNN
+0.18%
$2.72
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RGTZ
-20.27%
$14.90
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
AMC
-0.72%
$2.73
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
MARA
+0.36%
$19.22
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
DVLT
+5.14%
$2.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.